[CHAG与CAG预激方案治疗难治性及复发性急性髓系白血病的对比评估] - Suppr | 超能文献

[Comparative evaluation of CHAG and CAG priming regimen for treatment of refractory and relapsed acute myeloid leukemia].

作者信息

Chen Lin, Wei Xu-dong, Yin Qin-song

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2012 Jun;33(6):484-6.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Comparative evaluation of CHAG and CAG priming regimen for treatment of refractory and relapsed acute myeloid leukemia].

Zhonghua Xue Ye Xue Za Zhi. 2012 Jun;33(6):484-6.

2

Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia.

Leuk Res. 2015 Aug;39(8):805-11. doi: 10.1016/j.leukres.2015.04.006. Epub 2015 Apr 20.

3

Increasing the dose of aclarubicin in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) can safely and effectively treat relapsed or refractory acute myeloid leukemia.

Int J Hematol. 2014;99(5):603-8. doi: 10.1007/s12185-014-1528-8. Epub 2014 Mar 13.

4

Cladribine with Granulocyte Colony-Stimulating Factor, Cytarabine, and Aclarubicin Regimen in Refractory/Relapsed Acute Myeloid Leukemia: A Phase II Multicenter Study.

Oncologist. 2020 Nov;25(11):e1663-e1670. doi: 10.1634/theoncologist.2020-0818. Epub 2020 Sep 21.

5

Efficacy of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) compared to Hyper-CVAD regimen as salvage chemotherapy in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia.

Leuk Res. 2015 Mar;39(3):323-8. doi: 10.1016/j.leukres.2015.01.003. Epub 2015 Jan 16.

6

Cytarabine, aclarubicin and granulocyte colony-stimulating factor regimen represents an effective and safe salvage regimen for patients with acute myeloid leukemia refractory to first course of induction chemotherapy.

Leuk Lymphoma. 2013 Nov;54(11):2452-7. doi: 10.3109/10428194.2013.776679. Epub 2013 Apr 2.

7

Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemia.

Leuk Res. 2007 Oct;31(10):1383-8. doi: 10.1016/j.leukres.2007.02.009. Epub 2007 Apr 8.

8

Increasing aclarubicin dosage of the conventional CAG (low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor) regimen is more efficacious as a salvage therapy than CAG for relapsed/refractory acute myeloid leukemia.

Leuk Res. 2015 Dec;39(12):1353-9. doi: 10.1016/j.leukres.2015.09.014. Epub 2015 Sep 18.

9

Salvage chemotherapy with low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming in patients with refractory or relapsed acute myeloid leukemia with translocation (8;21).

Leuk Res. 2011 May;35(5):604-7. doi: 10.1016/j.leukres.2010.11.003. Epub 2010 Dec 3.

10

[Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming in 50 patients with relapsed acute myeloid leukemia].

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Jun;17(3):760-4.

引用本文的文献

1

[The clinical efficacy of the patients of acute myeloid leukemia with FLT3-ITD positive treated with sorafenib in combin ation with CHAG regimen].

Zhonghua Xue Ye Xue Za Zhi. 2016 May 14;37(5):419-21. doi: 10.3760/cma.j.issn.0253-2727.2016.05.013.